Ocugen, Inc.
OCGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $1 | $1 |
| % Growth | 27.6% | -7.3% | 93.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $1 | $1 | $1 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $11 | $8 | $10 | $8 |
| G&A Expenses | $8 | $7 | $6 | $6 |
| SG&A Expenses | $8 | $7 | $6 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $15 | $16 | $15 |
| Operating Income | -$18 | -$14 | -$15 | -$14 |
| % Margin | -1,006% | -1,004.7% | -979.1% | -1,811.5% |
| Other Income/Exp. Net | -$2 | -$1 | -$1 | -$0 |
| Pre-Tax Income | -$20 | -$15 | -$15 | -$14 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20 | -$15 | -$15 | -$14 |
| % Margin | -1,144.5% | -1,073.5% | -1,036.5% | -1,816.8% |
| EPS | -0.066 | -0.051 | -0.053 | -0.048 |
| % Growth | -30.7% | 4% | -10.3% | – |
| EPS Diluted | -0.066 | -0.051 | -0.053 | -0.048 |
| Weighted Avg Shares Out | 304 | 292 | 292 | 291 |
| Weighted Avg Shares Out Dil | 304 | 292 | 292 | 291 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$18 | -$13 | -$14 | -$13 |
| % Margin | -1,015.2% | -937.2% | -917.8% | -1,733.2% |